Status:
COMPLETED
Prevalence of Asthma and Allergies Among Children in UAE
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
Brief Summary
Multicenter, cross-sectional study to recruit a random sample of 6000 children via school class registers: 3000 children aged 13-14 years and 3000 children aged 6-7 years.
Detailed Description
Multicenter, cross-sectional study to recruit a random sample of 6000 children via school class registers: 3000 children aged 13-14 years and 3000 children aged 6-7 years.Standard ISAAC core questions...
Eligibility Criteria
Inclusion
- Children with age 6 to 7 years or with age 13 to 14 years at the time of questionnaires completion, and residing in Dubai and the Northern Emirates of UAE.
- Children aged 6 to 7 years or 13 to14 years, whose legal guardians give their consent.
- Able to give assent in the 13 to 14 years group.
- Able to comprehend and answer the questionnaire themselves in the 13 to 14 years group.
Exclusion
- Aged 13 to 14 years and unable to answer the questionnaire due to physical or mental disability.
- Parent or legal guardian refuses sign and return consent for the 6 to 7 years group and the 13 to 14 years group.
Key Trial Info
Start Date :
April 30 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 26 2019
Estimated Enrollment :
3737 Patients enrolled
Trial Details
Trial ID
NCT03878680
Start Date
April 30 2019
End Date
June 26 2019
Last Update
July 17 2020
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Ajman, United Arab Emirates
2
Research Site
Dubai, United Arab Emirates
3
Research Site
FUJ, United Arab Emirates
4
Research Site
Ras al-Khaimah, United Arab Emirates